Upload File

 · 2019. 1. 28. · 4å ákj arquie/à ákj pharmaceutica (roche) fi derazantinib ( bal087)...

  • Home
  • Documents
  •  · 2019. 1. 28. · 4å ákJ ArQuIe/à ákJ Pharmaceutica (Roche) fi derazantinib ( BAL087) Tecentriq (atezolizumab) ákJ 0 Derazantinib (BAL087) (FGFR) ( *2040 Peter Qingzhe Thiel
7

Upload: others

Post on 29-Jan-2021

1 views

Category:

Documents


0 download

Report

TRANSCRIPT

  • 幻灯片1幻灯片2幻灯片3幻灯片4幻灯片5幻灯片6幻灯片7

KEZBAN ACAR 2ÄÏJcJ ÁkJ =£ÚÝtÏ tÚÄ Á t

mofcom.gov.cnimages.mofcom.gov.cn/ltfzs/202001/20200120153734107.pdf · 13 . fib 10% , Ffr , ákJ . IÉJ FJ ; 50 ìŒ fi ; 10 -E -E . ákJ . 24 fib fiŽ 020 , iT ákJ Il k , E ákJ

2013-05-28 (1970—) , k, - Fudan Universityfdjpkc.fudan.edu.cn/_upload/article/files/d2/e5/569fd5b... · 2018. 1. 20. · 2013-05-28 (1970—) , k, , ÁkJ , , ÁkJ "84 ¥ : àíJ

 · 2020. 4. 15. · 35900 16800 1698 10 16980 20 33960 849 51789 51800 6055.62 ákJ 12 20376 30278.1 50654.1 50700 ìžÿJ: ákJ ákJ 500/0ì+#,

 · 2018. 7. 25. · 10 El , 10 El ) , 1.1k ( ákJ èlkYJffi ákJ h Yr ákJ . F] I-áJ FfrC±b El ákJ -H- á'kJ 30 ) åžB. ( ( ) åžB. 24 ( ( ) ) ) Z ákJ ; èlkYJFfr; ñû o 0

Tecentriq Bula Prof V005 - Diálogo Roche · Tecentriq ® Roche atezolizumabe APRESENTAÇÕES ... (stratified log-rank test at two-sided level of 5%) como segue: Etapa 1) População

河南省卫生健康委员会 · 2017. 2. 20. · ákJ ÈL ákJ fik-ñž, (fit E) #ùk, (E) eh, (FOB) ákJ ; 10

FGFR Genetic Alterations Predict for Sensitivity to …...the novel anticancer drug NVP-BGJ398 and showed that FGFR genetic alterations are the most signifi - cant predictors for

1103 (2019) 1858 (2019) 0114 1986 100 2 1103 ) ákJ ...imgcdn.gpai.net/upload/courtfile/2019-10/201910141623173410.pdf · 1103 (2019) 1858 (2019) 0114 1986 100 2 1103 ) ákJ: .. 1103

, o ákJ Local LAN TAU E News Îfij ákJ jJ[] ákJ ákJ SING AO ... · , o ákJ Local LAN TAU E News Îfij ákJ jJ[] ákJ ákJ SING AO DAILY àíJ

C 2019) 12 & , ákJ pkJ , pkJ€¦ · C 2019) 12 & , ákJ pkJ , pkJ , 12 &hJ, 6

2020001004 2220200012 2020 45 F] 19 , IkJ, ákJ 0 ákJ, 2000.4

-.3.— ; 42 ákJ 13 , ìJll , ákJ 0 , 0 ih , , , ákJ , EH JJÐJO€¦ · -.3.— ; 42 ákJ 13 " , ìJll , ákJ 0 , 0 ih , , , ákJ , EH JJÐJO . Created Date: 1/18/2016 9:46:39

hbj.nanjing.gov.cnhbj.nanjing.gov.cn/hbyw/hpsp/202011/P... · 2020. 11. 23. · ákJ (2015) 299 ) ( 2000 8 & 4) ákJ , ákJ ákJ pkJ . 60 (3) )ÿìžk ( IVJßL) 1) fib . WII] -E fiq;

S49076 – nový vysoko-aktívny inhibítor MET, AXL a FGFR tyrozín kináz

swj.zhengzhou.gov.cnswj.zhengzhou.gov.cn/u/cms/swj/201804/101645446u7x.pdf · 2018 )Tkhï, 2 018 C 2018) 63 ákJ "E 4—138" ákJ IÃJ . JTkùkX ákJ . ákJ ( JTk C 2017) 37 & ) ,

戸田ひさよしの自由自在ホームページ · ñ7cD 22 E ( ± 70 D DÉM 2,000 ákJ . 110, ákJ H) fi 23

ákJ€¦ · ákJ , ákJ 12 ,

GMC , — 20144, iffkLÿ4hòÝr, 20144, 38 , ill ákJ 3t -Ûj PR ... · GMC , — 20144, iffkLÿ4hòÝr, 20144, 38 , ill ákJ 3t -Ûj PR" "—PR" ákJ ákJ k M BAA ákJ , ,

 · 70 ákJ —l < I b E L B IC ìHlJ 70 -E ákJ ákJ 70 D & < A D 70 52 17 A . (3) 13 < o B o & 9 93 7 lc 7k < 5 D 87 50 o 50 £ D O b b D lc 4

dfs.bjcscn.comdfs.bjcscn.com/group1/M00/01/2E/CgAAal4efrmAfeQBAHpVkQS9H5… · fiŽ 20 ákJ , 3000—6000 GAR) ákJ 6000 fib fib 50 k 100 , 10 2019 9 20194 12

academic.ntue.edu.tw · (A)ÐI ' (D)hž (A) — ákJ ákJ visual ákJ (A)åhd+ k á Jùk 16.#define NBYN(X) , int n = 5; NBYN(n+ 1) , (D)30 (A)35 (B)36

, mf'F -F , % fiE ËX7FåafJLkfJL ( ) fiE HN 33 · -fi , VA WTO fio , , , fiE fiE EH fiE ± ûE ákJ fiE ákJ . Created Date: 2/3/2016 11:21:59 AM

 · , (oem) Ékj — ( bev) o (hevzev) (sic) , ákj ( Ékj /leŽ— , 2020 ctimes 23

Vinda 1985 4, 2007 ákJ Dr. Libresse Drypers k 2008 8.5 40

厦门建筑废土砂石综合管控平台 · C 2017) 49 & ( 2017 ) 8 2017 (20171 12 & ) (2017 hk) ( (20171 20&), ákJ ákJfik . ákJ C 2009) 36%) ( C 2014) , ákJ o fib ,

29415 , 7626 ákJ 0 , ákJRYc 10 o 2020 , CEO 4000 , , åkJ ...chinavi.jp/member/level/200108.pdf · 29415 , 7626 ákJ " " 0 , " ákJRYc 10 o 2020 , CEO 4000 " " , , åkJ , ákJ 21k

atezolizumab TECENTRIQ 1200 mg, solution à diluer pour

39 ájáj , ákJ 38 ákJmsho/book.files/濁社十年組.pdf · 39 ájáj , ákJ 38 ákJ . 41 40 rþ ákJ . Created Date: 4/10/2017 6:39:38 PM

M 7 1) D < D o 74 b D z 5} D E a) DE D ákJ ákJ E íì b …1995/07/03  · M 7 1) D < D o 74 b D z 5} D E a) DE D ákJ ákJ E íì b U D U O) D Z J* fr9 D D D D z D E 74 (ùÈ1)

Tecentriq® (atezolizumab) w leczeniu chorych na …bipold.aotm.gov.pl/assets/files/zlecenia_mz/2018/016/AW/... · 2018. 3. 8. · Tecentriq® (atezolizumab) w leczeniu chorych na

N03 (1792) 2020 30 ákJ ákJ (TED 6765-8904 (FAX) …fc06331220171211.web2.blks.jp/20news/200526.pdfN03 (1792) 2020 30 ákJ ákJ (TED 6765-8904 (FAX) 6765-8905 l@mtb. big lobe. ne

Presentación de PowerPoint · costa , ffij Blanca DIIJ ákJ —r LED 09 ákJ , A—cero Krion , Vondom : 2014.08 08 06 07 SEP 2014 id+Cl 05 , 7 06 09 08 061

( ákJ) - mhlw · ( ákJ) - mhlw ... ( ákJ)

 · 2017. 12. 25. · 48 [email protected] 3. 5 29 El Ilk ákJ +6 FJ 26 USBKEY 2 åbEùkÃllk) USBKEY 3. 24 6 FJ 15 6 15 ákJ --- , 12 FJ 10 0 26 FJ 8 ákJ ákJ 5 FJ 10-16